Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Rewards and cashback rewards can fund extra debt payments. Learn how Using Rewards Or Cashback To Accelerate Debt Payoff can shorten your payoff timeline.
18,334 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The YieldMax PYPL Option Income Strategy ETF is under pressure as its strategy to harvest option premiums collides wi...
A new industry focus centers on converting existing leads. Real estate teams report faster traction by prioritizing f...
A new Los Angeles exhibit invites you to look beyond the iconic white dress and pink gowns. This personal-finance fri...
A teen who left school to work on his dad’s site rose to a six-figure construction business by 22. The story mirrors ...
A divorced retiree learns, at age 64, that she can claim up to 50% of her ex-spouse's Social Security record, lifting...
Microsoft rolled out a fresh coding AI family at Build, aiming to accelerate developer tooling. Investors will watch ...
Two Maverick Capital co-CIOs warn of an air pocket between AI infrastructure and productivity, signaling a market tur...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
NEXA Lending CEO Mike Kortas introduces evoLend, a new servicing platform approved to handle government-backed loans,...
A Goldman Sachs economist offers reality on AI adoption timing, arguing that productivity gains from AI are likely to...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...